{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:10:10Z","timestamp":1696309810963},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T00:00:00Z","timestamp":1369699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes"],"published-print":{"date-parts":[[2013,9]]},"abstract":"Abstract<\/jats:title>Background<\/jats:title>Self\u2010efficacy plays a critical role in diabetes self\u2010care. Herein we explore factors contributing to decreased insulin therapy self\u2010efficacy in insulin\u2010na\u00efve patients with type 2 diabetes mellitus (T2DM<\/jats:styled-content>) initiating and managing insulin therapy over 36 weeks.<\/jats:p><\/jats:sec>Methods<\/jats:title>The study was conducted within an international, randomized clinical trial comparing two insulin therapies administered by insulin pen in patients with T2DM<\/jats:styled-content> inadequately controlled with oral antihyperglycemic medications. Patients completed the S<\/jats:styled-content>elf\u2010E<\/jats:styled-content>fficacy about I<\/jats:styled-content>nsulin T<\/jats:styled-content>herapy Q<\/jats:styled-content>uestionnaire (SEITQ<\/jats:styled-content>) at baseline and endpoint. Patients also completed patient\u2010reported measures assessing expectations about insulin therapy at baseline and perceptions about insulin therapy and insulin\u2010delivery system (IDS<\/jats:styled-content>) satisfaction at endpoint. Baseline and endpoint SEITQ<\/jats:styled-content> scores were compared. Using prespecified criteria, patients were classified as having \u201cdecreased\u201d or \u201cno change\/improved\u201d insulin self\u2010efficacy. Demographic, clinical, and patient\u2010reported variables were entered into a logistic regression model with decreased insulin self\u2010efficacy (yes or no) as the dependent variable.<\/jats:p><\/jats:sec>Results<\/jats:title>Baseline and endpoint SEITQ<\/jats:styled-content> data were available for 450 insulin\u2010na\u00efve T2DM<\/jats:styled-content> patients (mean age 59 years; 53% female; 57% Caucasian; mean baseline HbA1c<\/jats:styled-content> 9.4%; 80.0\u2009mmol\/mol). Insulin therapy self\u2010efficacy improved from baseline to endpoint (74.0 vs 77.5; P<\/jats:italic>\u2009<\u20090.001). Logistic regression analysis indicated that lower IDS<\/jats:styled-content> satisfaction (P<\/jats:italic>\u2009<\u20090.0001), lower IDS<\/jats:styled-content> social acceptability (P\u2009=<\/jats:italic>\u20090.004), and more positive expectations of insulin therapy (P<\/jats:italic>\u2009<\u20090.0001) were associated with decreased insulin self\u2010efficacy.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>A candid discussion between clinicians and their insulin\u2010na\u00efve T2DM<\/jats:styled-content> patients about the benefits and challenges of insulin therapy may prevent unrealistic expectations that could potentially undermine insulin self\u2010efficacy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1753-0407.12037","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T08:12:22Z","timestamp":1363248742000},"page":"358-367","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expectations about insulin therapy, perceived insulin\u2010delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self\u2010efficacy in patients with type 2 diabetes after 36 weeks insulin therapy (2\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u7ecf\u8fc736\u5468\u7684\u80f0\u5c9b\u7d20\u6cbb\u7597\u540e\uff0c\u60a3\u8005\u5bf9\u80f0\u5c9b\u7d20\u6cbb\u7597\u7684\u671f\u671b\u3001\u611f\u77e5\u7684\u80f0\u5c9b\u7d20\u7ed9\u836f\u88c5\u7f6e\u7684\u793e\u4f1a\u63a5\u53d7\u6027\u4ee5\u53ca\u5bf9\u80f0\u5c9b\u7d20\u6cbb\u7597\u7684\u6ee1\u610f\u5ea6\u90fd\u53ef\u4ee5\u5bfc\u81f4\u80f0\u5c9b\u7d20\u6cbb\u7597\u81ea\u6211\u6548\u80fd\u611f\u7684\u4e0b\u964d)"],"prefix":"10.1111","volume":"5","author":[{"given":"Risa P.","family":"Hayes","sequence":"first","affiliation":[{"name":"Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Curtis","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza","family":"Ilag","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayme","family":"Wong","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Funnell","sequence":"additional","affiliation":[{"name":"Michigan Center for Diabetes Translational Research Ann Arbor Michigan USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,5,28]]},"reference":[{"key":"e_1_2_7_2_1","volume-title":"Social Foundations of Thought and Action: A Social Cognitive Theory","author":"Bandura A","year":"1986"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1207\/S15324796ABM2601_01"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e3180514d57"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2011.11.002"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmq086"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.3.240"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2006.01930.x"},{"key":"e_1_2_7_9_1","unstructured":"American Diabetes Association.Living with diabetes. Available from:www.diabetes.org\/living\u2010with\u2010diabetes\/treatment\u2010and\u2010care\/medication\/insulin\/(accessed 7 August 2012)."},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1710"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/014572170102700309"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02176.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02363.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01287.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-2671(09)33278-5"},{"key":"e_1_2_7_16_1","first-page":"A","article-title":"Expectations about and experiences with insulin therapy questionnaires: A preliminary validation study","volume":"17","author":"Hayes RP","year":"2008","journal-title":"Qual Life Res"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1037\/0033-295X.84.2.191"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0145721706291760"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0124"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90061-6"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2008.0123"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-007-9222-4"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.05.011"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.11.2673"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.12.033"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/014572170403000220"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-S089"},{"key":"e_1_2_7_28_1","first-page":"577","article-title":"Removing barriers to insulin use","volume":"60","author":"Minze MG","year":"2011","journal-title":"J Fam Pract"}],"container-title":["Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1753-0407.12037","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1753-0407.12037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T12:52:48Z","timestamp":1696251168000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1753-0407.12037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,28]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/1753-0407.12037"],"URL":"https:\/\/doi.org\/10.1111\/1753-0407.12037","archive":["Portico"],"relation":{},"ISSN":["1753-0393","1753-0407"],"issn-type":[{"value":"1753-0393","type":"print"},{"value":"1753-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,28]]},"assertion":[{"value":"2012-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}